Waste Management Firm Opens Michigan Office, Ann Arbor’s Aastrom Grows


T&M Associates, a national engineering, environmental services, and consulting firm based in New Jersey, has opened its first office in Michigan to serve the automotive and waste management industries. 

The new office, at 39555 Orchard Hill Place in Novi, will offer auditing and program development/implementation, regulatory compliance and permitting, site investigation and remediation, risk assessment, due diligence, and transactional support, says Ihsan Al-Fayyomi, senior vice president and environmental services business unit leader at T&M.

Additionally, the company offers underground and aboveground storage tank evaluation and investigation, industrial hygiene, grants and funding, energy efficiency, transportation engineering, water resources, storm water management, and construction administration.

Al-Fayhomi says Natalie Pryde, who specializes in regulatory compliance at the local, federal, and global levels, will lead the Novi office. She brings nearly 15 years of environmental, health and safety, and compliance experience with General Motors, Ford, FIAT Chrysler Automobiles and numerous public and private clients in the sector. 

T&M also appointed environmental geologist Nathan Hull as a solid waste specialist, His team will provide a broad portfolio of services to clients throughout the region. Hull comes from T&M Associates’ Ohio regional office and brings nearly 20 years of experience in construction inspection, quality assurance, and environmental investigation. 

“Natalie’s automotive and regulatory leadership, combined with Nathan’s environmental expertise, enables us to bring best-in-class services to Detroit and enhance our offerings in the greater Midwest market,” Al-Fayyomi, says. 

T&M has nearly 400 employees and operates in 16 office locations throughout Delaware, Indiana, Kentucky, Massachusetts, Pennsylvania, and Ohio. 

 IN OTHER NEWS, Ann Arbor-based Aastrom Biosciences Inc., a developer of patient-specific expanded cellular therapies for the treatment of severe diseases and conditions, has announced plans to change its corporate name to Vericel Corp. and move its headquarters to Cambridge, Mass.

“The proposed name change and plan to move our headquarters to Cambridge are the next steps in the transformation of Aastrom from a clinical-stage company to a fully integrated, commercial-stage specialty biologics company,” says Nick Colangelo, Aastrom’s president and CEO.

“The new corporate name reflects our leading position in the cell therapy market, and our expanded presence in the vibrant Cambridge biotechnology community will increase our access to both talent and technology as we continue to grow our company,” Colangelo says.

The corporate name change is subject to the approval of Aastrom’s shareholders. Aastrom will continue to maintain manufacturing facilities in Ann Arbor as well as in Cambridge.

Aastrom’s Ann Arbor location is primarily involved with the production of a cell therapy treatment for people with heart disease. However, Michel says management is looking for ways to expand their operations in Michigan. “We’ve made a few key hires there and we do have a few functions that we are considering moving to Ann Arbor,” says Michel.